Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Analysis: New drugs drive prostate cancer market
Analysis: New drugs drive prostate cancer market
Analysis: New drugs drive prostate cancer market
Submitted by
admin
on September 19, 2011 - 6:08pm
Source:
Yahoo/AP
News Tags:
prostate cancer
Dendreon
Exelixis
JNJ
MDV3100
Medivation
Provenge
cabozatinib
Zytiga
Headline:
Analysis: New drugs drive prostate cancer market
Do Not Allow Advertisers to Use My Personal information
